Risk-Adapted Postmastectomy Radiotherapy Strategies Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study

被引:0
|
作者
Li, M. [1 ]
Yue, J. [2 ]
Wan, X. [3 ]
Hua, B. [4 ]
Yang, Q. [5 ]
Yang, P. [6 ]
Zhang, Z. [7 ]
Pei, Q. [8 ]
机构
[1] Beijing Hosp, Dept Radiat Oncol, Natl Ctr Gerontol, Beijing, Peoples R China
[2] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Shandong, Peoples R China
[3] Sun Yat Sen Univ, Dept Radiat Oncol, Affiliated Hosp 6, Guangzhou, Peoples R China
[4] Beijing Hosp, Dept Breast Canc Surg, Natl Ctr Gerontol, Beijing, Peoples R China
[5] Shandong Univ, Qilu Hosp, Jinan, Peoples R China
[6] Cent South Univ, Xiangya Sch Med, Key Lab Translat Radiat Oncol, Dept Radiat Oncol,Hunan Canc Hosp,Affiliated Hosp, Changsha, Peoples R China
[7] Cent South Univ, Xiangya Hosp, Dept Radiat Oncol, Changsha, Peoples R China
[8] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2033
引用
收藏
页码:E14 / E15
页数:2
相关论文
共 50 条
  • [1] Risk-Adapted Postmastectomy Radiotherapy Decision Based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer: A Multicenter Study
    Li, Ming
    Yue, Jinbo
    Wan, Xiangbo
    Hua, Bin
    Yang, Qiuan
    Yang, Pei
    Zhang, Zijian
    Pei, Qian
    Han, Weidong
    Xu, Yaping
    Xia, Xuefeng
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [2] Risk-adapted Postmastectomy Radiotherapy based on Prognostic Nomogram for pT1-2N1M0 Breast Cancer
    Li, M.
    Yue, J.
    Wan, X.
    Hua, B.
    Yang, Q.
    Yang, P.
    Zhang, Z.
    Pei, Q.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S509 - S509
  • [3] Risk-Adapted Postmastectomy Radiation Therapy for pT1-2N1M0 Breast Cancer: A Single Institution Study
    Li, M.
    Wang, S. L.
    Jin, J.
    Fang, H.
    Tang, Y.
    Tang, Y.
    Li, N.
    Chen, B.
    Qi, S.
    Song, Y. W.
    Liu, Y.
    Lu, N. N.
    Hua, R.
    Li, Y. X.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E29 - E29
  • [4] The significance of risk stratification through nomogram-based assessment in determining postmastectomy radiotherapy for patients diagnosed with pT1-2N1M0 breast cancer
    Wei, Chao
    Kong, Jie
    Han, Huina
    Wang, Xue
    Gao, Zimeng
    Wang, Danyang
    Zhang, Andu
    Zhang, Jun
    Liu, Zhikun
    [J]. RADIATION ONCOLOGY, 2024, 19 (01)
  • [5] Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay
    Zhang, Lina
    Zhou, Mengli
    Liu, Yueping
    Du, Furong
    Tang, Jiyu
    Wang, Ning
    Song, Chao
    Geng, Cuizhi
    Duan, Huijun
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (10) : 1801 - 1808
  • [6] Effect of tumor-infiltrating lymphocytes depending on the presence of postmastectomy radiotherapy on the prognosis in pT1-2N1M0 breast cancer
    Zhang, Lina
    Tang, Tiantian
    Liu, Lei
    Li, Chunxiao
    Li, Yuntao
    Geng, Cuizhi
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [7] Is it beneficial for patients with pT1-2N1M0 breast cancer to receive postmastectomy radiotherapy? An analysis based on RecurIndex assay (vol 149, pg 1801, 2021)
    Zhang, L.
    Zhou, M.
    Liu, Y.
    Du, F.
    Tang, J.
    Wang, N.
    Song, C.
    Geng, C.
    Duan, H.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (11) : E7 - E8
  • [8] High-Risk pT1-2N0 Breast Cancer may Benefit from Postmastectomy Radiotherapy: A Risk Stratification Analysis Based on Nomogram
    Huang, H.
    Yang, Y.
    Liao, L.
    Hao, J.
    Zhou, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E17 - E17
  • [9] Development and External Validation of a Nomogram to Predict the Benefit of Regional Node Irradiation in Patients with pT1-2N1M0 Breast Cancer
    Sun, G.
    Wen, G.
    Zhang, Y. J.
    Tang, Y.
    Jing, H.
    Zhao, X.
    Chen, S.
    Jin, J.
    Song, Y.
    Liu, Y.
    Fang, H.
    Tang, Y.
    Qi, S.
    Li, N.
    Chen, B.
    Lu, N.
    Li, Y.
    Wang, S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E23 - E24
  • [10] Risk-Adapted Postmastectomy Radiation Therapy for Patients with Clinical T1-2N0-1 Breast Cancer after Neoadjuvant Chemotherapy
    Wang, X.
    Yin, Z.
    Xu, L.
    Wang, Q.
    Zhao, L.
    Yuan, Z.
    Wang, P.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E595 - E596